Company / Working Capital per Share
Editas Medicine, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.42
FY2025
5-year range
$1.42 / $7.36
FY2021-FY2025
Trend
-45.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 4 consecutive years, from $7.36 in FY2021 to $1.42 in FY2025.
Based on SEC 10-K filings.
1.42 in FY2025 with a 5-year CAGR of -26.5%.
Declined from $4.03 to $1.42 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -31.0%
- 5-Year CAGR
- -26.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Editas Medicine, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 45.2% year-over-year.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | -45.2% |
| FY2024 | $2.59 | -35.7% |
| FY2023 | $4.03 | -7.0% |
| FY2022 | $4.33 | -41.1% |
| FY2021 | $7.36 | +10.8% |
| FY2020 | $6.64 | -19.8% |
| FY2019 | $8.28 | +8.8% |
| FY2018 | $7.61 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026